Maine drug disposal bill dies
This article was originally published in The Tan Sheet
Executive Summary
The Maine Senate indefinitely postpones legislation passed by the House that would have impelled manufacturers to contribute to an "Unused Pharmaceutical Disposal Program Fund." The Senate placed LD 821 in legislative files March 26, effectively killing it. The Consumer Healthcare Products Association opposed the bill and favors consumer education on safe drug disposal (1"The Tan Sheet" March 22, 2010, In Brief)
You may also be interested in...
CHPA opposes Maine bill
The Consumer Healthcare Products Association opposes a bill approved by Maine's House of Representatives that would require drug manufacturers to fund a system for disposing of unwanted Rx and OTC drugs. A CHPA spokeswoman said the trade group instead supports consumers using "more effective means of ensuring safe medicine disposal which not only protect the environment, but also prevent illegitimate access to drugs, decrease potential abuse and limit accidental poisonings." CHPA backs the SMARxT Disposal campaign, which educates consumers on proper disposal of unwanted medicines and which the American Pharmacists Association supports. The bill received a 91-51 vote March 17 and moves next to the Senate
Vanda Comes Up Empty Handed As US Supreme Court Denies Hetlioz Appeal
Vanda looks likely to have to face up to unimpeded US generic competition to its core Hetlioz brand, after a further denial in its litigation against ANDA sponsors Teva and Apotex.
EU: Good News For IVDs And For Future Transparency Of Medtech Compliance
The IVD industry has long been awaiting a further extension of the deadlines for compliance with the IVD Regulation and for the launch date of the Eudamed database to be brought forward.